Search
for
Sort by
Research 271–300 of 358
- Ubiquity and Diversity of Human-Associated Demodex Mites
- Repurposing of approved cardiovascular drugs
- Dissection of genetic variation and evidence for pleiotropy in male pattern baldness
- The Clinical Presentation of Systemic Lupus Erythematosus
- Genome-wide meta-analysis identifies novel loci conferring risk of acne vulgaris
- Are there temporal subtypes of premenstrual dysphoric disorder?: using group-based trajectory modeling to identify individual differences in symptom change
- A double-blind, placebo-controlled study of inositol in trichotillomania
- A regulatory perspective on pharmacokinetic/pharmacodynamic modelling
- Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model
- Chinese SLE Treatment and Research group (CSTAR) registry 2009–2019: Major clinical characteristics of Chinese patients with systemic lupus erythematosus
- Taste disorders and alopecia in myasthenia gravis
- Androgens in SARS-CoV-2 Coronavirus Infections
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results
- Burden of immune-related skin diseases worldwide, 1991–2021: insights and prediction from the Global Burden of Disease Study
- Influence of Saw palmetto and Pygeum africana extracts on the urinary concentrations of endogenous anabolic steroids: Relevance to doping analysis
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- Global Landscapes of Human Phenotypic Variation in Inherited Traits
- Climacteric Commentaries
- Electron beam tomography quantitation of coronary calcium and assessment for ischemic coronary disease: a complement to stress testing
- Pharmacology of Induced Artificial Platelets in Regenerative Medicine: Beyond Transfusion
- Features of skinfold thickness in Ukrainian men with alopecia areata
- Association between SQSTM1 dysregulation and risk in alopecia areata: a Mendelian randomization study
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- LB1053 Dysregulation of antioxidant enzyme PRDX5 in alopecia areata
- 0348 Adverse event reports of alopecia for sunscreen ingredients and branded products
- Atherogenesis: Estrogen Induction of Polysialylated nCAM (PSA-nCAM) Blocks Monocyte Capture by Vascular Endothelial Cells
- Formulation-by-Design of Efinaconazole Spanlastic Nanovesicles for Transungual Delivery Using Statistical Risk Management and Multivariate Analytical Techniques
- Diagnosis and Management of Glaucoma
- Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata
- Evolution and genetic architecture of sex-limited polymorphism in cuckoos